Alaunos Therapeutics, Inc.

TCRT

Amendment

Ownership

8.60%

Total Shares

189,061

Issuer CIK

1107421

CUSIP

98973P309

Event Date

Feb 23, 2026

Accepted

Mar 5, 2026, 11:33 AM

SEC EDGARView Original Filing

Reporting Persons (21)

Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

Name	Type	% of Class	Aggregate	Sole Voting	Shared Voting
Price Adrian	Individual	8.60%	189,061	0	189,061
Gareth Downing	Individual	0.90%	19,552	19,552	189,061
John Nicholls	Individual	0.80%	16,743	16,743	189,061
Richard Jones	Individual	0.70%	16,000	16,000	189,061
Chris Cole	Individual	0.70%	15,856	15,856	189,061
Andrew Turner	Individual	0.60%	13,035	13,035	189,061
Richard Kotey	Individual	0.60%	12,530	12,530	189,061
Edward Jones	Individual	0.50%	11,750	11,750	189,061
Emma Babb	Individual	0.50%	10,366	10,366	189,061
Chris Butterworth	Individual	0.50%	10,700	10,700	189,061
Matthew Robbins	Individual	0.50%	10,036	10,036	189,061
Phillip James Stead	Individual	0.50%	11,012	11,012	189,061
Greg Arnold	Individual	0.50%	10,735	10,735	189,061
Michelle Douglas	Individual	0.40%	8,494	8,494	189,061
Stephen Hennessy	Individual	0.30%	7,108	7,108	189,061
Arif Chaudrey	Individual	0.30%	6,423	6,423	189,061
Colin Craig	Individual	0.30%	7,000	7,000	189,061
Carl Ware	Individual	0.10%	1,721	1,721	189,061
HexagonONE Ltd	CO	0.00%	0	0	189,061
Alimenta Holding Limited	CO	0.00%	0	0	189,061
Krakatau Holding Limited	CO	0.00%	0	0	189,061

Disclosure Items (7)

Security Title

Common stock

Issuer Name

Alaunos Therapeutics, Inc.

Issuer Address

501 E LAS OLAS BLVD, FORT LAUDERDALE, TX, 33301

Filing Persons

The below persons are collectively referred to herein as the Reporting Persons. Each of the Reporting Persons files this Schedule 13D jointly. The Reporting Persons are filing this Schedule 13D jointly, as they may be considered a Group under Section 13(d)(3) of the Act. However, neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Reporting Persons that such a group exists. Chris Butterworth Richard Jones Edward Jones Gareth Downing Richard Kotey Chris Cole Arif Chaudrey Emma Babb Colin Craig John Nicholls Carl Ware Andrew Turner Matthew Robbins Phillip James Stead Stephen Hennessy Greg Arnold Michelle Douglas HexagonONE Ltd Krakatau Holding Limited Alimenta Holding Limited

Business Address

Chris Butterworth: 12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom Richard Jones: 28 Jedburgh Street, Blantyre, Glasgow, South Lanarkshire, G72 0SU, United Kingdom Edward Jones: 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom Gareth Downing: 14 Osier Way, Banstead, SM7 1LL, United Kingdom Richard Kotey: 13 Mendez Way, London, SW15 5GA, United Kingdom Chris Cole: 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom Arif Chaudrey: 25 Bays Crescent, Spencers Wood, Reading, RG7 1DF, United Kingdom Emma Babb: 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom Colin Craig: 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom John Nicholls: 41 Lea Castle Drice, Lea Castle, Kiddermister, Worcs, DY10 3FB, United Kingdom Carl Ware: 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom Andrew Turner: 26 Sun Vale Avenue, Todmorden, West Yorkshire, OL14 6TP, United Kingdom Matthew Robbins: 42 Tattersall Road, Yate, Bristol, BS37 7GW, United Kingdom Phillip James Stead: 113 Dartmouth Avenue, Wallsal, West Midlands, WS3 1SP, United Kingdom Stephen Hennessy: 57 Regent House, Station Road, Strood, Kent, ME2 4WQ, United Kingdom Greg Arnold: 1 Hickling Close, Long Eaton, Nottingham, NG10 3TE, United Kingdom Michelle Douglas: 13 Mendez Way, London, SW15 5GA, United Kingdom HexagonONE Ltd: Oleander Building, Suites OL-7 & OL-8, 13A J.R. O'Neal Drive, Port Purcell, Tortola, British Virgin Islands Krakatau Holding Limited: Keyway Chambers, 3rd Floor, Quastisky Building, Road Town, Tortola, British Virgin Islands Alimenta Holding Limited: Keyway Chambers, 3rd Floor, Quastisky Building, Road Town, Tortola, British Virgin Islands

Principal Occupation

Chris Butterworth: self-employed electrician;12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom Richard Jones: manager at Balfour Beatty; Huntly Road, Glasgow, G52 4DZ, United Kingdom Edward Jones: self-employed software developer; 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom Gareth Downing: ops manager at M Group; Gunnells Eood Rd, Stevenage, United Kingdom Richard Kotey: tutor at United Colleges Group; 26 Paddington Green, W2 1NB, United Kingdom Chris Cole: self-employed carpenter; 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom Arif Chaudrey: petroleum engineer at KBR Consulting; KT22 7NL, Letterhead, United Kingdom Emma Babb: housewife; 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom Colin Craig: support worker/subcontractor at various companies; 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom John Nicholls: field service engineer at Clearmark Solutions; Olympic House, Nottingham, NG15 0DP, United Kingdom Carl Ware: self-employed IT consultant; 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom Andrew Turner: ops manager at Urbasers; 3 Sidings Court, Doncaster DN4 5NU, United Kingdom Matthew Robbins: student at Bristol University; Beacon House Bristol, BS8 1QU, United Kingdom Phillip James Stead: events manager at Walsal FC; Beacon House Bristol, BS8 1QU, United Kingdom Stephen Hennessy: engineer at Go Fix; Beechcroft Farm ind estate, TN15 7HX, United Kingdom Greg Arnold: project supervisor at CITY; Caldonia House Glasgow, United Kingdom Michelle Douglas: manager at NHS; PO Box 130, Morden, SM4 9EF, United Kingdom HexagonONE Ltd: unknown Krakatau Holding Limited: unknown Alimenta Holding Limited: unknown

Convictions

Chris Butterworth: No Richard Jones: No Edward Jones: No Gareth Downing: No Richard Kotey: No Chris Cole: No Arif Chaudrey: No Emma Babb: No Colin Craig: No John Nicholls: No Carl Ware: No Andrew Turner: No Matthew Robbins: No Phillip James Stead: No Stephen Hennessy: No Greg Arnold: No Michelle Douglas: No HexagonONE Ltd: No Krakatau Holding Limited: No Alimenta Holding Limited: No

Citizenship

Chris Butterworth: United Kingdom Richard Jones: United Kingdom Edward Jones: United Kingdom Gareth Downing: United Kingdom Richard Kotey: United Kingdom Chris Cole: United Kingdom Arif Chaudrey: United Kingdom Emma Babb: United Kingdom Colin Craig: United Kingdom John Nicholls: United Kingdom Carl Ware: United Kingdom Andrew Turner: United Kingdom Matthew Robbins: United Kingdom Phillip James Stead: United Kingdom Stephen Hennessy: United Kingdom Greg Arnold: United Kingdom Michelle Douglas: United Kingdom HexagonONE Ltd: British Virgin Islands Krakatau Holding Limited: British Virgin Islands Alimenta Holding Limited: British Virgin Islands

Chris Butterworth: personal funds Richard Jones: personal funds Edward Jones: personal funds Gareth Downing: personal funds Richard Kotey: personal funds Chris Cole: personal funds Arif Chaudrey: personal funds Emma Babb: personal funds Colin Craig: personal funds John Nicholls: personal funds Carl Ware: personal funds Andrew Turner: personal funds Matthew Robbins: personal funds Phillip James Stead: personal funds Stephen Hennessy: personal funds Greg Arnold: personal funds Michelle Douglas: personal funds HexagonONE Ltd: working capital Krakatau Holding Limited: working capital Alimenta Holding Limited: working capital

On February 24, 2026, counsel for Adrian Price sent a letter on behalf of the Reporting Persons to counsel of Alaunos Therapeutics, Inc. (the "Company"), and requested that the Company's counsel provide the letter to the Company's Board of Directors ("Board"). In this letter, Mr. Price proposed a private placement whereby HexagonONE Ltd, Alimenta Holding Limited and Krakatau Holding Limited (the "Investors") would purchase $7,000,000 of securities of the Company subject to mutually agreeable definitive documentation and customary closing conditions. The securities purchased by the Investors would be equity or equity-linked securities, with the purchase price to be negotiated in good faith, taking into account market conditions, the Company's liquidity needs, and long-term shareholder alignment. The Investors proposed that the private placement close as soon as practicable following Board approval and completion of documentation and shareholder approval (if required by Nasdaq rules). The letter requested the Board meet with Mr. Price within five business days to begin term sheet negotiation and due diligence. The letter also reiterated the Reporting Persons' nomination of Gerald Bruce to the Board and requested that the Board appoint Mr. Bruce as a director. The letter stated that if the Board did not engage meaningfully with Mr. Price within this five business day period, then the Reporting Persons may seek to purchase additional shares of the Company in the market or undertake a tender offer to shareholders. The letter also mentioned that the Reporting Persons could undertake an investor relations campaign if the Board did not engage meaningfully with Mr. Price. In the letter, Mr. Price reserved all rights belonging to the Reporting Persons as shareholders of the Company. If consummated, it its anticipated that the proposed private placement would result in a change of control of the Company. The letter sent by Mr. Price is attached hereto as Exhibit 21. This letter was sent as part of the Reporting Persons' efforts to help create shareholder value, and the Reporting Persons intend to continue these efforts. The Reporting Persons may purchase and sell common stock of the Company in their sole discretion and at such times as they deem convenient, subject to applicable law. Other than as set forth above, the Reporting Persons do not intend to take any other actions described in subsections (a) through (j) of Item 4 of Schedule 13D at this time; however, they reserve the right to do so.

Percentage of Class

The information contained in Rows 7, 8, 9, 10, 11, and 13 of each Reporting Person's cover page to this Schedule 13D (including the footnotes thereto), and in Items 2 and 3 of this amendment, are incorporated by reference into this Item 5. Adrian Price disclaims beneficial ownership of the securities discussed herein.

Number of Shares

Transactions

The Reporting Persons have not conducted any transactions in Alaunos securities in the past 60 days.

Shareholders

N/A

Date of 5% Ownership

N/A

The Reporting Persons have entered into a Joint Filing Agreement, which is set forth hereto as Exhibit 1 and incorporated by reference, and Exhibit 22. The Reporting Persons have granted Adrian Price a power of attorney to sign and file this Schedule 13D (and any amendments) and the Joint Filing Agreement with the Securities and Exchange Commission. These powers of attorney are set forth as Exhibits 23-25. Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of Alaunos.

Exhibit 1 Joint Filing Agreement, incorporated by reference Exhibit 2 Power of Attorney: Chris Butterworth, incorporated by reference Exhibit 3 Power of Attorney: Richard Jones, incorporated by reference Exhibit 4 Power of Attorney: Edward Jones, incorporated by reference Exhibit 5 Power of Attorney: Gareth Downing, incorporated by reference Exhibit 7 Power of Attorney: Richard Kotey, incorporated by reference Exhibit 8 Power of Attorney: Chris Cole, incorporated by reference Exhibit 9 Power of Attorney: Arif Chaudrey, incorporated by reference Exhibit 10 Power of Attorney: Emma Babb, incorporated by reference Exhibit 11 Power of Attorney: Colin Craig, incorporated by reference Exhibit 12 Power of Attorney: John Nicholls, incorporated by reference Exhibit 13 Power of Attorney: Carl Ware, incorporated by reference Exhibit 14 Power of Attorney: Andrew Turner, incorporated by reference Exhibit 15 Power of Attorney: Matthew Robbins, incorporated by reference Exhibit 16 Power of Attorney: Phillip James Stead, incorporated by reference Exhibit 17 Power of Attorney: Stephen Hennessy, incorporated by reference Exhibit 18 Power of Attorney: Greg Arnold, incorporated by reference Exhibit 19 Power of Attorney: Michelle Douglas, incorporated by reference Exhibit 20 Letter to Alaunos Board of Directors, incorporated by reference Exhibit 21 Proposal to the Board of Directors of Alaunos Therapeutics (TCRT), incorporated by reference Exhibit 22 Joint Filing Agreement for HexagonONE Ltd, Krakatau Holding Limited, and Alimenta Holding Limited Exhibit 23 Power of Attorney: HexagonONE Ltd Exhibit 24 Power of Attorney: Krakatau Holding Limited Exhibit 25 Power of Attorney: Alimenta Holding Limited

Alaunos Therapeutics, Inc.

Reporting Persons (21)

Disclosure Items (7)

Item 1 — Security and Issuer

Item 2 — Identity and Background

Item 3 — Source of Funds

KEYItem 4 — Purpose of Transaction

Item 5 — Interest in Securities

Item 6 — Contracts & Arrangements

Item 7 — Exhibits